FDA wants to use more real-world data and calls again for early-phase trials reformnews2025-12-15T20:45:38+00:00December 15th, 2025|Endpoints News|
FDA speeds up review of J&J’s multiple myeloma combo treatment following positive datanews2025-12-15T19:25:21+00:00December 15th, 2025|Endpoints News|
Kyverna to take autoimmune CAR-T to FDA after success in stiff person syndrome trialnews2025-12-15T16:10:23+00:00December 15th, 2025|Endpoints News|
Milestone finally wins FDA approval for arrythmia nasal spraynews2025-12-15T01:31:55+00:00December 15th, 2025|Endpoints News|
Covid vaccine deaths review sent to top of FDA, but with far less certain conclusions, sources saynews2025-12-12T20:36:22+00:00December 12th, 2025|Endpoints News|
CHMP calls to reject Anavex’s Alzheimer’s pill over impurities, side effects and weak efficacynews2025-12-12T17:27:18+00:00December 12th, 2025|Endpoints News|
FDA broadens label for Amgen’s Uplizna as it enters rare disease competitionnews2025-12-12T12:03:56+00:00December 12th, 2025|Endpoints News|
CDC report underscores benefit of Covid-19 vaccines in kidsnews2025-12-11T20:51:34+00:00December 11th, 2025|Endpoints News|
GSK’s new antibiotic wins gonorrhea approvalnews2025-12-11T19:19:37+00:00December 11th, 2025|Endpoints News|
USAntibiotics scores sped-up approval for amoxicillinnews2025-12-10T19:11:01+00:00December 10th, 2025|Endpoints News|
